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Introduction
In neonatal lupus, macrophage activation syndrome
(MAS) is very rare. Now, we reported a newborn infant
with MAS born from a untreated mother with adult onset
Still disease.
Objectives
In infant born from a mother with autoimmune disease,
clinical manifestations of neonatal MAS were similar with
neonatal sepsis. We have to consider neonatal MAS from
a mother with autoimmune disease.
Methods
We reported a newborn infant with macrophage activation
syndrome (MAS) born from a mother with positive anti-
nuclear (ANA) and anti-SSA/Ro antibodies. The 2,500 g
girl was born at 37+6 weeks of gestation in good condition.
Mother had been diagnosed with adult onset Still disease
10 years previously. During pregnancy, she did not take
any medication as she was free of symptoms. The baby
was admitted due to tachypnea and fever 12 hours after
birth. Initial laboratory findings showed mild anemia with
thrombocytopenia, and mild elevation of alanine amino-
transferase (ALT). Anti-platelet antibody was not detected.
A work-up of infectious etiology, including agents respon-
sible for congenital infection, was negative.
Results
On the 10th hospital day (HD), the baby showed severe
abdominal distension caused by hepatosplenomegaly, and
persistent, high fever despite empirical antibiotic therapy.
We identified positive ANA and anti-SSA/Ro antibodies
from the infant, compatible with those found in the
mother. The baby’s electrocardiography was normal. On
the 18th HD, she showed deterioration of overall condition
with high ferritin, ALT, and profound thrombocytopenia.
The baby received intravenous immunoglobulin, steroid
(pulse and oral), and cyclosporine. Gene study for perforin,
K-ras, and N-ras was negative. Her general condition
showed improvement after treatment, although mild fever
and organomegaly remained. We maintained high dose
steroid and cyclosporine, and all medication was tapered
and stopped at 12 weeks of age.
Conclusion
We suggest that transplacental transfer of maternal auto-
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